Social Life Network Inc (OTCMKTS: WDLF) Decentral Life Steady Run Northbound Brewing as Tech Business Incubator Reports Record Revenues, Prepares to Uplist and Spins Off TBIs
Social Life Network Inc (OTCMKTS: WDLF) is making a steady run northbound in recent trading moving up 12% on Friday on 43.5 million shares traded or about $122,000 in dollar volume. The stock is currently under heavy accumulation and breaking out northbound from its mid-August highs. From here the first real resistance is at a penny, a level WDLF reached in August of 2021 with the same share structure. On February 9, 2021 WDLF ran to $0.044 highs when OS was roughly half of what it is today meaning if WDLF made a similar run today to the same market valuation it would reach about $0.02 per share.
It’s easy to see why WDLF is currently under heavy accumulation because there are a lot of big things happening here. With the able guidance of CEO Ken S. Tapp, a Harvard Business School graduate and venture capitalist WDLF is changing its name to Decentral Life, and planning to uplist to a national exchange; NYSE or NASDAQ and just reported record revenues of $500,000 + in Q3 up well over 300% from the $140,000 in revenues in Q2 according to the latest update from the Company. Decentral Life has also collected on accounts receivable and currently has over $350,000 in cash in the treasury. WDLF is an SEC filer and will soon be OTCQB on OTCMarkets, the Company has very little debt of just $540k which is why there has been no dilution and OS has stayed the same over the past year and a half. On September 30, 2022, the Company filed a 1-A-W cancelling a 2 billion shares offering meaning the OS stays the same at 7.39 billion shares outstanding.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Social Life Network Inc (OTCMKTS: WDLF) dba Decentral Life is a technology business incubator that is focused on blockchain and AI technology with a goal of taking the Company’s participating in the incubator program and help them reach a liquidity event like an IPO, a security token offering or an acquisition. Decentral Life maintains a 15% stake in these Companies as well as an ongoing licensing agreement with each Company to receive 5% of their revenues.
MjLink.com Inc. a wholly owned subsidiary of Decentral Life is a cloud-based cannabis social network and digital media company based in Denver, Colorado. MjLink operates as a multinational cannabis technology and digital media organization with four industry specific social networks: WeedLife.com, a consumer-to-consumer social network, MjLink.com, a business-to-business social network, HempTalk.com, a business-to-consumer social network, and MjInvest.com, a cannabis industry investor network that produces the MjMicro Capital Conference.
The WDLF Token is an Ethereum ERC20 Utility Token that is mined by users of the social networking and e-marketplace platform that is powered by the Social Life technology business incubator program (TBI), a division of Decentral Life. Learn more about the Social Life Network TBI program by going to https://www.WDLF.ai/about-wdlf to support the token there is the WDLF crypto exchange which allows the tokens to be traded for other cryptocurrencies. The WDLF crypto wallet holds WDLF Tokens for cryptocurrency transactions. The initial Coin offering was in January 2022.
Decentral Life is led by founder and CEO Ken S. Tapp, a Harvard Business School graduate and a founder and co-founder of multiple internet technology companies and worked for years in the internet technology industry, including executive positions at MOVE.com as well as a director or executive at more than two dozen internet technology startups. As a venture capitalist, Mr. Tapp has built and exited, through initial public offerings and acquisitions, 13 technology startups over the past 2 decades.
The Company’s president is Mr. Todd Markey, a wall street exec who has spent the last decade working in finance and the capital markets and is an expert for micro-cap to small cap companies in expanding their investor and public relations. Additionally, he has assisted companies in the pre-IPO and up-listing process, from the OTC markets onto Nasdaq and NYSE stock exchanges.
Microcapdaily first covered WDLF on March 2, 2020 a day when the stock ran from $0.0009 to $0.0012. We covered it again on the weekend of December 6, 2020 after the stock had closed at $0.0016 the Friday before as the stock was just embarking on its major run northbound to highs of $0.044 on February 9, 2021, a move of more than 2000% from the pps when this article was written: MjLink Reg A Offering; the Rise of Social Life Network Inc (OTCMKTS: WDLF)
To Find out the inside Scoop on WDLF Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
The most exciting part of WDLF by far is its Tech Business Incubator (TBI) program that currently includes: BLOCK, CycleFans, HuntPost, GolfLynk, FutPost, LikeRE, MjLink, RaceScene, RacketStar, and SpaceZE.
The Company’s sister Company’s netcube accelerator program has seen significant expansion and anticipates going from 4 to 6 Company’s currently to as many as 40 to 60 Company’s going through the program in 2023. Decentral Life is expecting to add a number of new Company’s to its TBI program in 2023 and will be ramping up the program in Q4 in preparation. Part of this growth means increasing office space and to this end, the Company is moving its headquarters to its office in Scottsdale, Arizona and will be expanding into new office spaces in Tempe, Arizona to help support the founders and CEOs of AI and blockchain related Company’s.
Decentral Life’s TBI Companies have been expanding over the year and the Company will continue to help support the new offices including a new office in Mineral Park, California across the street from Facebook and Instagram’s offices. There is also a new office in Greenwood Park, Colorado as well as a new office in Las Vegas, Nevada supporting in part Mj Link.
Decentral Life and its TBI’s will be presenting at the Next Deck Walk Investors Conferences on October 10 and 11 this week to approximately 100 retail and institutional investors. Investors in the Company should also be on the lookout in the coming days for another 8k announcing the Company’s next shareholder update. In Q4, Decentral Life will be going on a road show in preparation for an uplisting to NYSE or NASDAQ a task for which Ken S. Tapp and Todd Markey are especially qualified for. The Company will be presenting at multiple micro-cap events giving Decentral Life additional exposure to analysts, high net worth individuals and institutional investors.
https://t.co/lKQavB8obu If you missed the shareholder update on September 30th, here is the link. Thank you everyone for your continued support of our company and the support of one another as fellow shareholders. Have a safe extended weekend! $WDLF
— Decentral Life (OTC: WDLF / Token: WDLF) (@sociallifenetwk) October 8, 2022
For More on WDLF Subscribe Right Now!
Currently trading at a $20 million market valuation WDLF has 7,394,792,892 shares outstanding which has not changed over the past year and a half. The Company has over $350,000 in the treasury, very little debt and just reported record revenues of $500,000 + in Q3 up well over 300% from the $140,000 in revenues in Q2 and the Company’s highest revenues quarter ever. There are a lot of exciting things currently happening at WDLF; last week the Company finalized its months long effort to spin off 2 divisions of Mj Link; the weedlife division and the hemptalk division into separate Companies that shareholders will own a 15% stake in each Company. The remaining assets of Mj Link will then be acquired. HuntPost has been busy working on going public via a SPAC along with a roll out once public of multiple trade shows in the hunting, fishing, camping, outdoor space. Management is working hard behind the scenes in order to get the 10k out early this year in the 3rd or 4th week of October. Also, in Q4 the Company plans to continue to work with and support HuntPost, hemptalk as well as weedlife in their liquidity events and prepare for 2023’s growth with the Company’s TBI program. Decentral Life has a very indepth, corporate website reminiscent of a Company listed on a national exchange. They also do really neat commercials for their TBIs which can be seen here.Currently trading at $0.0028 and moving northbound steadily WDLF has a ton of room for growth from current levels and with a significantly stronger Company then they were in early 2021 the stock could dwarf that run under the right market conditions. We will be updating on WDLF when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with WDLF.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in WDLF either long or short and we have not been compensated for this article. We have never spoken to any principals of WDLF or any major shareholders or 3rd parties. Much of the information here comes from the Company’s latest update located here.
Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.
“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”
$ACON Aclarion Announces New Engagement with The London Clinic and London Spine Clinic
Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.
$ACON Watching for volume and run. Aclarion Announces New Engagement with The London Clinic and London Spine Clinic
What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers.
To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.
They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.
Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”
$ACON Watching for volume and run. Aclarion Announces New Engagement with The London Clinic and London Spine Clinic
It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.
The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.
We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.
Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.
They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.
$Amtx EPA approved kaboom another winner from rara koko private discord – we know the news and catalyst first stamp now 1025am 5/19/23 alert sent to subscribers cell phone all over the world -super fast super quick. pic.twitter.com/2RVHENSnqd
They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.
To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.
The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.
Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.
Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?
The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.
(told ya) Aemetis Setting Up For Short Squeeze $AMTX our 1-year price target is $17 to $22 https://t.co/kMxOgQYEk2
The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.
The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies.
The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.
We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12. This represents an impressive 137% increase; the volume has been off the hook. If you look at their historical chart, $GSIT had meager volume, sometimes as low as 300 shares traded in a day. If you do the math, that’s less than $500 worth of shares traded in a day – safe to say it was virtually illiquid.
So what happened, and what drove the stock to trade 50M shares with filings or news releases?
After an in-depth examination, GSI Technology, Inc. appears to have experienced a notable turning point in its market trajectory. The catalyst for this transformation was the company’s prominent feature on Fox News, triggering an exponential dissemination of information across various platforms. It is worth highlighting an intriguing phenomenon that tends to transpire in such circumstances: purchasing shares often induces a ripple effect, encouraging further buying activity.
With Fox News bringing the company into the spotlight and stimulating investor interest, a domino effect occurred among astute day traders who eagerly seized the opportunity to partake in this promising venture. Consequently, the trading volume for GSI Technology, Inc. skyrocketed to unprecedented levels, surpassing all previously recorded thresholds.
$GSIT GSIT +64% this am: Number one pick for AI on stew varney fox business moments ago. Analyst said if your broker recommends Invidia fire them this is the company that could be leader of the world and AI.
This surge in volume stands as a testament to the immense enthusiasm that enveloped the market as traders recognized the tremendous potential inherent in $GSIT. This collective enthusiasm resulted in an extraordinary demonstration of market engagement, reflecting a widespread acknowledgment of the company’s significance and the opportunities it presents.
This development showcases the power of influential media coverage and underscores the intriguing dynamics that can arise when investor sentiment aligns with a compelling market narrative.
To Discover the Inside Scoop on GSIT, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Founded in 1995, GSI Technology Inc. has established itself as a prominent provider of semiconductor memory solutions. The company is focused on introducing new products that capitalize on its core strengths, which include radiation-hardened memory products for extreme environments and Gemini, an advanced processing unit (APU) designed to enhance performance in various artificial intelligence (AI) applications. Headquartered in Sunnyvale, California, GSI Technology operates sales offices in the Americas, Europe, and Asia.
$GSIT been doing this a long time & always makes me laugh NO one wanted GSIT at $1.50 or CASH on hand but killing it at $3.20 $$$
GSI Technology is on the verge of reporting its earnings next week, and the company operates in the storage business, which supports the development of highly efficient AI chips. Traditionally, computing involves separate chips for storage and computation, necessitating frequent data exchange. This process incurs significant power consumption and presents scalability challenges.
To address these limitations, GSI Technology has developed a groundbreaking solution called In-memory processing. This innovation substantially reduces computation time from minutes to seconds, milliseconds, or even microseconds. Notably, it also significantly diminishes power consumption and overall cost of ownership. The key to this improvement lies in the massive parallel data processing offered by GSI’s technology, featuring two million-bit processors per chip compared to thousands found in standard graphic processing units (GPUs). Consequently, the system becomes more scalable, enabling efficient and accelerated AI processing.
By streamlining the computing process and integrating storage and computation on a single chip, GSI Technology aims to revolutionize AI processing. This approach offers notable benefits regarding power efficiency, computational speed, and scalability, making it an attractive solution for a wide range of AI applications.
$GSIT earnings May 16 after the market close. Low volume domestic semi conductor. My favorite sector. I have buys at 1.60 and 1.64
In conclusion, GSI Technology, Inc. is poised to deliver innovative semiconductor memory solutions emphasizing AI chip development. The company aims to reduce computation time, power consumption, and total ownership cost through its In-memory processing technology while significantly improving scalability. With its upcoming earnings report, investors and industry observers will closely watch the company’s progress in the storage business and AI chip development.
We will update you on GSIT when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening with GSIT.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Jeremy Eisenberg
October 9, 2022 at 5:41 pm
They are planning an uplist to the NYSE or NASDAQ, NOT the OTCQB.